Cite
HARVARD Citation
Westhovens, R. et al. (n.d.). THU0191 Novel formulation of ct-p13 for subcutaneous administration in patients with rheumatoid arthritis: initial results from a phase i/iii randomised controlled trial. Annals of the rheumatic diseases. p. 315. [Online].